Impairment of mitochondrial function by minocycline

FEBS Journal

Volumn 276, Issue 6, 2009, Pages 1729-1738

  Kupsch, Kathleen ^a   Hertel, Silvia ^a   Kreutzmann, Peter ^a   Wolf, Gerald ^a   Wallesch, Claus Werner ^a   Siemen, Detlef ^a   Schönfeld, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Magnesium; Minocycline; Mitochondria; Neuroprotection; Permeability transition

Indexed keywords

CALCIUM ION; CHOLINE; CYTOCHROME C; DICYCLOHEXYLCARBODIIMIDE; MAGNESIUM ION; MINOCYCLINE; POTASSIUM CHLORIDE; SUCROSE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY BALANCE; IN VITRO STUDY; LIVER MITOCHONDRION; MALE; MEMBRANE DEPOLARIZATION; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; MITOCHONDRIAL RESPIRATION; MITOCHONDRION SWELLING; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; DICYCLOHEXYLCARBODIIMIDE; MAGNESIUM; MALE; MEMBRANE POTENTIALS; MINOCYCLINE; MITOCHONDRIA, LIVER; MITOCHONDRIAL SWELLING; NAD; OXIDATION-REDUCTION; RATS; RATS, WISTAR; TRIALKYLTIN COMPOUNDS;

RATTUS;

EID: 61349170168     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.06904.x     Document Type: Article

References (40)

1. Craven GR, Gavin R Fanning T (1969) The transfer RNA binding site of the 30 S ribosome and the site of tetracycline inhibition. Cold Spring Harb Symp Quant Biol 34, 129 137.
2. Vandekerckhove BN, Quirynen M van Steenberghe D (1998) The use of locally delivered minocycline in the treatment of chronic periodontitis. A review of the literature. J Clin Periodontol 25, 964 968.
3. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu DC et al. (2002) Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417, 74 78.
4. Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, Ferrante RJ, Kristal BS Friedlander RM (2003) Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease. Proc Natl Acad Sci USA 100, 10483 10487.
5. Haroon MF, Fatima A, Scholer S, Gieseler A, Horn TF, Kirches E, Wolf G Kreutzmann P (2007) Minocycline, a possible neuroprotective agent in Leber's hereditary optic neuropathy (LHON): studies of cybrid cells bearing 11778 mutation. Neurobiol Dis 28, 237 250.
6. Stack EC, Smith KM, Ryu H, Cormier K, Chen M, Hagerty SW, Del Signore SJ, Cudkowicz ME, Friedlander RM Ferrante RJ (2006) Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice. Biochim Biophys Acta 1762, 373 380.
7. Koistinaho M, Malm TM, Kettunen MI, Goldsteins G, Starckx S, Kauppinen RA, Opdenakker G Koistinaho J (2005) Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice. J Cereb Blood Flow Metab 25, 460 467.
8. Scarabelli TM, Stephanou A, Pasini E, Gitti G, Townsend P, Lawrence K, Chen-Scarabelli C, Saravolatz L, Latchman D, Knight R et al. (2004) Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DIABLO. J Am Coll Cardiol 43, 865 874.
9. Jordan J, Fernandez-Gomez FJ, Ramos M, Ikuta I, Aguirre N Galindo MF (2007) Minocycline and cytoprotection: shedding new light on a shadowy controversy. Curr Drug Deliv 4, 225 231.
10. Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T Koistinaho J (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95, 15769 15774.
11. Kraus RL, Pasieczny R, Lariosa-Willingham K, Turner MS, Jiang A Trauger JW (2005) Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J Neurochem 94, 819 827.
12. Wang J, Wei Q, Wang CY, Hill WD, Hess DC Dong Z (2004) Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem 279, 19948 19954.
13. Castanares M, Vera Y, Erkkila K, Kyttanen S, Lue Y, Dunkel L, Wang C, Swerdloff RS Hikim AP (2005) Minocycline up-regulates BCL-2 levels in mitochondria and attenuates male germ cell apoptosis. Biochem Biophys Res Commun 337, 663 669.
14. Alano CC, Kauppinen TM, Valls AV Swanson RA (2006) Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci USA 103, 9685 9690.
15. Brundula V, Rewcastle NB, Metz LM, Bernard CC Yong VW (2002) Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 125, 1297 1308.
16. Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM et al. (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6, 797 801.
17. Teng YD, Choi H, Onario RC, Zhu S, Desilets FC, Lan S, Woodard EJ, Snyder EY, Eichler ME Friedlander RM (2004) Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci USA 101, 3071 3076.
18. Fuks B, Talaga P, Huart C, Henichart J-P, Bertrand K, Grimee R Lorent G (2005) In vitro properties of 5-(benzylsulfonyl)-4-bromo-2-methyl-3(2H)- pyridazinone: a novel permeability transition pore inhibitor. Eur J Pharmacol 519, 24 30.
19. Leung AW Halestrap AP (2008) Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochim Biophys Acta 1777, 946 952.
20. Theruvath TP, Zhong Z, Pediaditakis P, Ramshesh VK, Currin RT, Tikunov A, Holmuhamedov E Lemasters JJ (2008) Minocycline and N-methyl-4-isoleucine cyclosporin (NIM811) mitigate storage/reperfusion injury after rat liver transplantation through suppression of the mitochondrial permeability transition. Hepatology 47, 236 246.
21. Mansson R, Hansson MJ, Morota S, Uchino H, Ekdahl CT Elmer E (2007) Re-evaluation of mitochondrial permeability transition as a primary neuroprotective target of minocycline. Neurobiol Dis 25, 198 205.
22. Fernandez-Gomez FJ, Galindo MF, Gomez-Lazaro M, Gonzalez-Garcia C, Cena V, Aguirre N Jordan J (2005) Involvement of mitochondrial potential and calcium buffering capacity in minocycline cytoprotective actions. Neuroscience 133, 959 967.
23. Durckheimer W (1975) Tetracyclines: chemistry, biochemistry, and structure-activity relations. Angew Chem Int Ed Engl 14, 721 734.
24. Barza M, Brown RB, Shanks C, Gamble C Weinstein L (1975) Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs. Antimicrob Agents Chemother 8, 713 720.
25. Beavis AD Powers MF (1989) On the regulation of the mitochondrial inner membrane anion channel by magnesium and protons. J Biol Chem 264, 17148 17155.
26. Nakashima RA, Dordick RS Garlid KD (1982) On the relative roles of Ca2 + and Mg2 + in regulating the endogenous K+/H+ exchanger of rat liver mitochondria. J Biol Chem 257, 12540 12545.
27. Bernardi P, Angrilli A, Ambrosin V Azzone GF (1989) Activation of latent K+ uniport in mitochondria treated with the ionophore A23187. J Biol Chem 264, 18902 18906.
28. Gauthier LM Diwan JJ (1979) Inhibition of K+ flux into rat liver mitochondria by dicyclohexylcarbodiimide. Biochem Biophys Res Commun 87, 1072 1079.
29. Martin WH, DiResta DJ Garlid KD (1986) Kinetics of inhibition and binding of dicyclohexylcarbodiimide to the 82,000-dalton mitochondrial K+/H+ antiporter. J Biol Chem 261, 12300 12305.
30. Powers MF Beavis AD (1991) Triorganotins inhibit the mitochondrial inner membrane anion channel. J Biol Chem 266, 17250 17256.
31. Schönfeld P, Gerke S, Bohnensack R Wojtczak L (2003) Stimulation of potassium cycling in mitochondria by long-chain fatty acids. Biochim Biophys Acta 1604, 125 133.
32. Cornet S, Spinnewyn B, Delaflotte S, Charnet C, Roubert V, Favre C, Hider H, Chabrier PE Auguet M (2004) Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocycline. Eur J Pharmacol 505, 111 119.
33. Beavis AD (1992) Properties of the inner membrane anion channel in intact mitochondria. J Bioenerg Biomembr 24, 77 90.
34. Caswell AH Hutchison JD (1971) Visualization of membrane bound cations by a fluorescent technique. Biochem Biophys Res Commun 42, 43 49.
35. Rall DP, Loo TL, Lane M Kelly MG (1957) Appearance and persistence of fluorescent material in tumor tissue after tetracycline administration. J Natl Cancer Inst 19, 79 85.
36. Schönfeld P, Schüttig R Wojtczak L (2002) Rapid release of Mg(2 +) from liver mitochondria by nonesterified long-chain fatty acids in alkaline media. Arch Biochem Biophys 403, 16 24.
37. +. FEBS Lett 100, 301 304.
38. Novgorodov SA, Gudz TI, Brierley GP Pfeiffer DR (1994) Magnesium ion modulates the sensitivity of the mitochondrial permeability transition pore to cyclosporin A and ADP. Arch Biochem Biophys 311, 219 228.
39. Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, Hilton JF, Spitalny GM, Macarthur RB, Mitsumoto H et al. (2007) Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol 6, 1045 1053.
40. Kupsch K, Parvez S, Siemen D Wolf G (2007) Modulation of the permeability transition pore by inhibition of the mitochondrial K(ATP) channel in liver vs. brain mitochondria. J Membr Biol 215, 69 74.